Hun-Sung Kim1,2, Chenglin Sun3, So Jung Yang1, Lin Sun3, Fei Li3, In Young Choi1, Jae-Hyoung Cho2, Guixia Wang3, Kun-Ho Yoon1,2. 1. 1 Department of Medical Informatics, College of Medicine, The Catholic University of Korea , Seoul, Republic of Korea. 2. 2 Department of Endocrinology and Metabolism, College of Medicine, The Catholic University of Korea , Seoul, Republic of Korea. 3. 3 Department of Endocrinology and Metabolism, The First Hospital of Jilin University , Changchun, China .
Abstract
OBJECTIVE: Large amounts of time and effort are needed to implement an Internet-based glucose monitoring system (IBGMS) in the clinical setting. This study was designed using research experience that was developed while implementing an IBGMS in Korea, and the research platform was modified to evaluate the efficacy of an IBGMS in controlling blood sugar in the Chinese population. METHODS: A randomized, open-label, parallel group design was used to evaluate the efficacy of an IBGMS among Chinese subjects with type 2 diabetes. Over a 6-month period, 182 subjects were evaluated in the IBGMS (n = 92) or control (n = 90) groups. RESULTS: After 3 months, the control group's HbA1c levels were reduced from 8.0% ± 0.8% to 7.3% ± 1.2% (p < 0.001) and the IBGMS group experienced a reduction from 7.9% ± 0.8% to 6.9% ± 0.7% (p < 0.001); the IBGMS group's end value was significantly lower (p = 0.014). The intragroup changes in the control and IBGMS groups were significant at the 3-month (p = 0.002) and 6-month (p < 0.01) follow-ups. Over this period, the HbA1c levels in the control group increased slightly (7.3% ± 1.1% to 7.4% ± 1.3%, p = 0.605), and the HbA1c levels in the IBGMS group decreased slightly (6.9% ± 0.7% to 6.7% ± 0.7%, p = 0.081). CONCLUSIONS: The IBGMS was effective in improving blood sugar levels among patients with diabetes. Therefore, IBGMS experience can be effectively transferred between institutions and countries.
RCT Entities:
OBJECTIVE: Large amounts of time and effort are needed to implement an Internet-based glucose monitoring system (IBGMS) in the clinical setting. This study was designed using research experience that was developed while implementing an IBGMS in Korea, and the research platform was modified to evaluate the efficacy of an IBGMS in controlling blood sugar in the Chinese population. METHODS: A randomized, open-label, parallel group design was used to evaluate the efficacy of an IBGMS among Chinese subjects with type 2 diabetes. Over a 6-month period, 182 subjects were evaluated in the IBGMS (n = 92) or control (n = 90) groups. RESULTS: After 3 months, the control group's HbA1c levels were reduced from 8.0% ± 0.8% to 7.3% ± 1.2% (p < 0.001) and the IBGMS group experienced a reduction from 7.9% ± 0.8% to 6.9% ± 0.7% (p < 0.001); the IBGMS group's end value was significantly lower (p = 0.014). The intragroup changes in the control and IBGMS groups were significant at the 3-month (p = 0.002) and 6-month (p < 0.01) follow-ups. Over this period, the HbA1c levels in the control group increased slightly (7.3% ± 1.1% to 7.4% ± 1.3%, p = 0.605), and the HbA1c levels in the IBGMS group decreased slightly (6.9% ± 0.7% to 6.7% ± 0.7%, p = 0.081). CONCLUSIONS: The IBGMS was effective in improving blood sugar levels among patients with diabetes. Therefore, IBGMS experience can be effectively transferred between institutions and countries.
Entities:
Keywords:
Diabetes mellitus; Internet-based glucose monitoring system (IBGMS); mobile health; telehealth
Authors: Hun Sung Kim; So Jung Yang; Yoo Jin Jeong; Young Eun Kim; Seok Won Hong; Jae Hyoung Cho Journal: Diabetes Metab J Date: 2017-06 Impact factor: 5.376
Authors: Yilin Yoshida; Suzanne A Boren; Jesus Soares; Mihail Popescu; Stephen D Nielson; Eduardo J Simoes Journal: Curr Diab Rep Date: 2018-10-18 Impact factor: 4.810
Authors: David Flood; Jessica Hane; Matthew Dunn; Sarah Jane Brown; Bradley H Wagenaar; Elizabeth A Rogers; Michele Heisler; Peter Rohloff; Vineet Chopra Journal: PLoS Med Date: 2020-11-12 Impact factor: 11.613